Lupin Limited has informed the Exchange regarding a press release dated December 25, 2021, titled "Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension".
Press Release Dec 25 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Dec 24 2021
- Press Release (Revised) Dec 14 2021
- Press Release Dec 14 2021
- Press Release Dec 10 2021
- Press Release Dec 03 2021
Later from Lupin
- Press Release Jan 07 2022
- Press Release Jan 19 2022
- Press Release Jan 27 2022
- Press Release Feb 01 2022
- Press Release Feb 03 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin